Northwire Canada EditionSunday, October 18, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Brookfield Asset Management Announces $1 Billion Commercial Paper Program

BAM · Price

Executive Summary

  • Brookfield Asset Management Ltd. announced the establishment of a $1 billion unsecured commercial paper program on a private‑placement basis.
  • The program provides an additional source of short‑term capital to diversify and strengthen Brookfield’s balance sheet.
  • Proceeds from any notes issued under the program will be used for general corporate purposes.

Key Details

  • Program Size: Up to $1 billion aggregate outstanding amount at any time.
  • Instrument Type: Unsecured commercial paper notes (the “notes”).
  • Placement Method: Private placement; notes are not registered under the U.S. Securities Act of 1933 and may only be offered pursuant to an exemption or registration.
  • Purpose of Proceeds: General corporate purposes, intended to further diversify and strengthen Brookfield’s balance sheet.
  • Regulatory Notice: The press release does not constitute an offer to sell or a solicitation of an offer to buy the notes; it is issued in accordance with Rule 135c under the Securities Act.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from BROOKFIELD ASSET MANAGEMENT LTD. CL A LV